Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC

Описание к видео Dr. Charles Ryan Discusses Abiraterone and Enzalutamide for mCRPC

Charles Ryan, MD, Associate Clinical Professor, Department of Medicine (Hematology/Oncology), University of California, San Francisco, discusses the utility of abiraterone and enzalutamide for patients with metastatic castration-resistant prostate cancer.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Комментарии

Информация по комментариям в разработке

Похожие видео